Lenalidomide, Melphalan, Prednisone, and Thalidomide (RMPT) for Relapsed/Refractory Multiple Myeloma.
Phase of Trial: Phase I/II
Latest Information Update: 12 May 2016
At a glance
- Drugs Lenalidomide (Primary) ; Melphalan (Primary) ; Prednisone (Primary) ; Thalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms RMPT
- 09 May 2016 Status changed from active, no longer recruiting to completed.
- 18 Mar 2010 Planned end date (Feb 2011) added as reported by ClinicalTrials.gov.
- 05 Dec 2009 Results presented at the 51st Annual Meeting and Exposition of the American Society of Hematology (ASH 2009).